Latisse®

Latisse® (bimatoprost 0.03%) is an FDA-approved ophthalmic solution designed to treat hypotrichosis by stimulating natural eyelash growth. As a prostaglandin analog, it extends the anagen (growth) phase of the hair cycle, resulting in longer, thicker, and darker eyelashes over time. Clinically proven to enhance lash density within 8 to 16 weeks, Latisse® is a trusted option among dermatologists, ophthalmologists, and aesthetic specialists managing patients seeking non-invasive eyelash enhancement.

Regular application of Latisse® provides gradual but significant improvement in eyelash appearance with minimal disruption to daily routines. The solution is applied once daily to the upper lash line using a sterile applicator, ensuring controlled and precise distribution. Medical professionals should educate patients on proper use to avoid adverse effects, such as unintended hair growth on adjacent skin or potential iris pigmentation changes.

Latisse® is commonly prescribed by dermatologists and ophthalmologists specializing in aesthetic and reconstructive treatments. Its efficacy and safety profile make it a preferred choice for patients seeking a clinically backed solution for insufficient eyelashes.

Disclaimers:

– For professional use only. Must be prescribed and administered by a licensed medical practitioner.

– Not for consumer self-administration without medical supervision.

– Patients should be informed of potential side effects, including periorbital skin darkening and iris pigmentation changes.

– This product should only be used in accordance with local regulations and clinical guidelines.